Private Equity
Andrea Alms Video: Money In Motion 146 - Migraine Drug Market
March 2025 - Private Equity
TRANSCRIPT
Hello. My name is Andrea Alms. I am a technology investor and financial manager and this is your Money in Motion. What is it? A migraine is a headache that can feel like throbbing or pounding pain on one side of your head. Migraines can also cause nausea, vomiting, and sensitivity of light and sound. At Templeton Health, they have an excellent chart that helps tell the difference between four common types of headaches, including migraines.
According to this infographic from Migraine at Work. About 1 in 6 employees live with migraine disease. Absenteeism is twice as high. The cost of the to the company is about 84 to $181,000 for every 1000 employees. Employees with migraines are more likely to experience other conditions, such as mental health, chronic pain, sleep disorder, and obesity. At Grandview, the global market was 5.64 billion in 2023 and is projected to reach a compound average growth rate of 11.9% from 2024 to 2030.
At Polaris Research Group, the market size was 4.34 billion in 2021, and the growth is expected to be 8.5% from 2018 to 2030. At Imarc Group, the market was 4.2 billion in 2023 and expected to reach 6.3 billion in 2032 and a growth rate of 4.3%. Averaging the averages, the market was 4.7 billion at 8.2% growth rate. Thank you.
This is your money. Your Money in Motion.